Literature DB >> 18727076

In-stent restenosis in bare metal stents versus sirolimus-eluting stents after primary coronary intervention for acute myocardial infarction and subsequent transcoronary transplantation of autologous stem cells.

Clemens Steinwender1, Robert Hofmann, Alexander Kypta, Juergen Kammler, Klaus Kerschner, Michael Grund, Kurt Sihorsch, Christian Gabriel, Franz Leisch.   

Abstract

BACKGROUND: Following stenting for acute myocardial infarction, transcoronary transplantation of granulocyte-colony stimulating factor (G-CSF) mobilized autologous stem cells (ASC) has been shown to result in an increased in-stent restenosis rate of bare metal stents (BMS). HYPOTHESIS: This study sought to compare the extent of neointimal growth in BMS and sirolimus-eluting stents (SES) after primary implantation, and subsequent transcoronary transplantation of G-CSF mobilized stem cells.
METHODS: Patients with stenting of the left anterior descending coronary artery for acute anterior myocardial infarction were randomly assigned to receive a BMS or SES. Intracoronary stem cell injection was performed after G-CSF application for at least 4 d and cell apheresis. The angiograms obtained after cell transplantation and after 6 mo were analyzed by quantitative coronary angiography.
RESULTS: We performed primary stenting and stem cell transplantion in 16 patients who received a BMS (n = 8) or an SES (n = 8). In 2 patients with a BMS, late stent thrombosis occurred after 58 d and 177 d, respectively. In the remaining patients, control angiography after 6 mo revealed in-stent restenosis of >50% in no patients with SES but in 4 patients with BMS (67%). Late lumen loss and in-stent plaque volume were significantly higher in patients with BMS compared with patients with SES.
CONCLUSIONS: Compared with BMS, SES impair in-stent intima hyperplasia after stenting for acute myocardial infarction and transcoronary transplantation of G-CSF mobilized ASC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18727076      PMCID: PMC6653443          DOI: 10.1002/clc.20235

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  12 in total

1.  Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction.

Authors:  Marc C Newell; Christopher R Henry; Christopher J G Sigakis; Barbara Tate Unger; David M Larson; Ivan J Chavez; M Nicholas Burke; Jay H Traverse; Timothy D Henry
Journal:  Am J Cardiol       Date:  2006-03-10       Impact factor: 2.778

2.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors:  Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

3.  Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.

Authors:  Jozef Bartunek; Marc Vanderheyden; Bart Vandekerckhove; Samer Mansour; Bernard De Bruyne; Pieter De Bondt; Inge Van Haute; Nele Lootens; Guy Heyndrickx; William Wijns
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

4.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

5.  Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.

Authors:  Hyun-Jae Kang; Hae-Young Lee; Sang-Hoon Na; Sung-A Chang; Kyung-Woo Park; Hyung-Kwan Kim; Song-Yi Kim; Ho-Joon Chang; Whal Lee; Won Jun Kang; Bon-Kwon Koo; Yong-Jin Kim; Dong Soo Lee; Dae-Won Sohn; Kyou-Sup Han; Byung-Hee Oh; Young-Bae Park; Hyo-Soo Kim
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

6.  Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction.

Authors:  Clemens Steinwender; Robert Hofmann; Jürgen Kammler; Alexander Kypta; Robert Pichler; Wilma Maschek; Gerhard Schuster; Christian Gabriel; Franz Leisch
Journal:  Am Heart J       Date:  2006-06       Impact factor: 4.749

7.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

Authors:  Masataka Sata; Akio Saiura; Atsushi Kunisato; Akihiro Tojo; Seiji Okada; Takeshi Tokuhisa; Hisamaru Hirai; Masatoshi Makuuchi; Yasunobu Hirata; Ryozo Nagai
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

8.  Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty.

Authors:  Edouard Cheneau; Seung-Woon Rha; Pramod K Kuchulakanti; Eugenio Stabile; Timothy Kinnaird; Rebecca Torguson; Augusto D Pichard; Lowell F Satler; Kenneth M Kent; Ron Waksman
Journal:  Catheter Cardiovasc Interv       Date:  2005-08       Impact factor: 2.692

9.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

Authors:  Volker Schächinger; Birgit Assmus; Martina B Britten; Jörg Honold; Ralf Lehmann; Claudius Teupe; Nasreddin D Abolmaali; Thomas J Vogl; Wolf-Karsten Hofmann; Hans Martin; Stefanie Dimmeler; Andreas M Zeiher
Journal:  J Am Coll Cardiol       Date:  2004-10-19       Impact factor: 24.094

10.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.

Authors:  Hyun-Jae Kang; Hyo-Soo Kim; Shu-Ying Zhang; Kyung-Woo Park; Hyun-Jai Cho; Bon-Kwon Koo; Yong-Jin Kim; Dong Soo Lee; Dae-Won Sohn; Kyou-Sup Han; Byung-Hee Oh; Myoung-Mook Lee; Young-Bae Park
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

View more
  2 in total

Review 1.  Drug-eluting stents versus bare-metal stents for acute coronary syndrome.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Janette Greenhalgh; Juliet Hounsome; Naqash J Sethi; Sanam Safi; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-08-23

2.  Myocardial restoration: is it the cell or the architecture or both?

Authors:  Duc Thang Vu; Eliana C Martinez; Theo Kofidis
Journal:  Cardiol Res Pract       Date:  2012-02-16       Impact factor: 1.866

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.